InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Johnson Chad Allen. Director active across 2 companies, notably Lumos Pharma, INC.. Cumulatively, 2 reports have been recorded. History available since 20 May 2021. The latest transaction was filed on 20 May 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations